| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 165 | 2022 | 954 | 21.580 |
Why?
|
| Secretory Vesicles | 14 | 2020 | 124 | 3.620 |
Why?
|
| Eosinophilia | 33 | 2021 | 541 | 3.260 |
Why?
|
| Hypereosinophilic Syndrome | 20 | 2023 | 93 | 3.070 |
Why?
|
| Lipid Metabolism | 27 | 2017 | 1885 | 2.140 |
Why?
|
| Cell Degranulation | 14 | 2020 | 287 | 2.100 |
Why?
|
| Leukocytes | 14 | 2016 | 2044 | 2.030 |
Why?
|
| Galectins | 4 | 2021 | 269 | 1.840 |
Why?
|
| Eicosanoids | 15 | 2017 | 279 | 1.740 |
Why?
|
| Organelles | 8 | 2013 | 264 | 1.460 |
Why?
|
| Cytoplasmic Granules | 17 | 2017 | 609 | 1.450 |
Why?
|
| Chemokine CCL11 | 17 | 2018 | 129 | 1.450 |
Why?
|
| Leukotriene C4 | 11 | 2019 | 97 | 1.450 |
Why?
|
| Inclusion Bodies | 14 | 2011 | 279 | 1.370 |
Why?
|
| Interleukin-4 | 14 | 2015 | 1147 | 1.280 |
Why?
|
| Cytokines | 28 | 2019 | 7324 | 1.250 |
Why?
|
| Microscopy, Electron | 16 | 2014 | 2646 | 1.190 |
Why?
|
| Lysophospholipase | 15 | 2020 | 63 | 1.180 |
Why?
|
| Churg-Strauss Syndrome | 8 | 2022 | 70 | 1.110 |
Why?
|
| Eosinophil Cationic Protein | 2 | 2018 | 9 | 1.050 |
Why?
|
| Arachidonic Acids | 16 | 2001 | 299 | 1.030 |
Why?
|
| Ribonucleases | 7 | 2013 | 284 | 0.980 |
Why?
|
| Lipids | 13 | 2019 | 3307 | 0.980 |
Why?
|
| Microscopy, Immunoelectron | 13 | 2016 | 319 | 0.980 |
Why?
|
| Leukotrienes | 5 | 2010 | 255 | 0.930 |
Why?
|
| Inflammation | 18 | 2019 | 10629 | 0.910 |
Why?
|
| Inflammation Mediators | 15 | 2017 | 1888 | 0.890 |
Why?
|
| Crystallization | 9 | 2019 | 525 | 0.870 |
Why?
|
| Cell Death | 5 | 2021 | 1705 | 0.860 |
Why?
|
| Hypersensitivity | 9 | 2020 | 1102 | 0.800 |
Why?
|
| Receptors, Leukotriene | 4 | 2010 | 123 | 0.800 |
Why?
|
| Interleukin-5 | 17 | 2018 | 273 | 0.780 |
Why?
|
| Brugia | 11 | 1992 | 24 | 0.750 |
Why?
|
| Chemokine CCL5 | 9 | 2018 | 209 | 0.750 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 623 | 0.740 |
Why?
|
| Mast Cells | 11 | 2014 | 1544 | 0.720 |
Why?
|
| Chemokines, CC | 11 | 2006 | 290 | 0.690 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2011 | 1475 | 0.690 |
Why?
|
| Cell Separation | 7 | 2014 | 1750 | 0.690 |
Why?
|
| Eosinophil Major Basic Protein | 5 | 2018 | 14 | 0.690 |
Why?
|
| Eosinophil Granule Proteins | 8 | 2021 | 30 | 0.680 |
Why?
|
| Receptors, CCR3 | 9 | 2018 | 62 | 0.660 |
Why?
|
| Receptors, Chemokine | 7 | 2006 | 670 | 0.640 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2018 | 164 | 0.630 |
Why?
|
| Th2 Cells | 5 | 2015 | 1061 | 0.620 |
Why?
|
| Arachidonic Acid | 15 | 2016 | 434 | 0.620 |
Why?
|
| Receptors, CCR7 | 2 | 2017 | 108 | 0.590 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 279 | 0.590 |
Why?
|
| Interleukin-16 | 7 | 2002 | 33 | 0.570 |
Why?
|
| Cysteine | 3 | 2010 | 871 | 0.570 |
Why?
|
| Chemotaxis | 2 | 2017 | 607 | 0.550 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 10 | 2002 | 329 | 0.540 |
Why?
|
| Transport Vesicles | 4 | 2010 | 83 | 0.530 |
Why?
|
| Glycoproteins | 10 | 2020 | 2266 | 0.520 |
Why?
|
| Tissue Embedding | 1 | 2014 | 43 | 0.500 |
Why?
|
| Immunity, Innate | 4 | 2017 | 2961 | 0.500 |
Why?
|
| Pulmonary Eosinophilia | 3 | 2012 | 82 | 0.490 |
Why?
|
| Sepharose | 4 | 2005 | 108 | 0.490 |
Why?
|
| Humans | 249 | 2023 | 743811 | 0.480 |
Why?
|
| Neutrophils | 20 | 2015 | 3718 | 0.480 |
Why?
|
| Microscopy, Electron, Transmission | 8 | 2022 | 712 | 0.470 |
Why?
|
| Filariasis | 12 | 1990 | 28 | 0.470 |
Why?
|
| Lymphokines | 6 | 1997 | 948 | 0.460 |
Why?
|
| Electron Microscope Tomography | 1 | 2013 | 18 | 0.460 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 204 | 0.450 |
Why?
|
| Cytoplasm | 11 | 2016 | 1536 | 0.450 |
Why?
|
| Integrins | 3 | 2013 | 846 | 0.440 |
Why?
|
| Animals | 103 | 2020 | 168660 | 0.440 |
Why?
|
| Antigen Presentation | 4 | 2010 | 1283 | 0.430 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 697 | 0.430 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 100 | 0.420 |
Why?
|
| Helminthiasis | 5 | 2010 | 66 | 0.420 |
Why?
|
| Cell Compartmentation | 7 | 2014 | 402 | 0.420 |
Why?
|
| Granulocytes | 3 | 2012 | 548 | 0.410 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2011 | 273 | 0.400 |
Why?
|
| Thymoma | 1 | 2013 | 186 | 0.400 |
Why?
|
| Phospholipases | 10 | 1990 | 72 | 0.390 |
Why?
|
| Flow Cytometry | 13 | 2015 | 5973 | 0.390 |
Why?
|
| Detergents | 1 | 2011 | 230 | 0.390 |
Why?
|
| Fibrosis | 3 | 2015 | 2030 | 0.380 |
Why?
|
| Immune System | 1 | 2016 | 807 | 0.380 |
Why?
|
| Thymus Neoplasms | 1 | 2013 | 268 | 0.380 |
Why?
|
| Platelet Activating Factor | 8 | 2005 | 149 | 0.380 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2017 | 2503 | 0.370 |
Why?
|
| Immunohistochemistry | 23 | 2014 | 11360 | 0.370 |
Why?
|
| Cell Fractionation | 2 | 2009 | 251 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2013 | 2938 | 0.360 |
Why?
|
| Receptors, Prostaglandin | 3 | 2019 | 57 | 0.360 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2010 | 57 | 0.350 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2013 | 547 | 0.350 |
Why?
|
| Intracellular Membranes | 2 | 2013 | 391 | 0.350 |
Why?
|
| Rhinoplasty | 1 | 2013 | 226 | 0.350 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2010 | 99 | 0.340 |
Why?
|
| Anthelmintics | 3 | 2006 | 62 | 0.340 |
Why?
|
| Thrombophilia | 1 | 2012 | 305 | 0.340 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 5 | 2014 | 98 | 0.340 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2009 | 313 | 0.340 |
Why?
|
| Myeloproliferative Disorders | 3 | 2010 | 606 | 0.340 |
Why?
|
| Lymph Nodes | 2 | 2017 | 3476 | 0.340 |
Why?
|
| Travel | 6 | 2001 | 788 | 0.340 |
Why?
|
| Phospholipases A | 2 | 2001 | 216 | 0.330 |
Why?
|
| Leukocyte Count | 8 | 2022 | 1588 | 0.330 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2002 | 371 | 0.330 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2009 | 3874 | 0.330 |
Why?
|
| Microscopy | 2 | 2011 | 896 | 0.330 |
Why?
|
| Intracellular Space | 2 | 2017 | 210 | 0.320 |
Why?
|
| Antigen-Presenting Cells | 2 | 2007 | 972 | 0.320 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2007 | 768 | 0.320 |
Why?
|
| Tropical Medicine | 2 | 2017 | 49 | 0.320 |
Why?
|
| Alum Compounds | 1 | 2008 | 33 | 0.320 |
Why?
|
| Filarioidea | 5 | 1990 | 9 | 0.320 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 10 | 2009 | 902 | 0.310 |
Why?
|
| Chemotaxis, Leukocyte | 10 | 2005 | 675 | 0.310 |
Why?
|
| Chemotactic Factors, Eosinophil | 4 | 2005 | 42 | 0.310 |
Why?
|
| Asthma | 14 | 2017 | 6010 | 0.300 |
Why?
|
| Schistosoma mansoni | 4 | 2018 | 149 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 6380 | 0.300 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 5 | 2014 | 379 | 0.300 |
Why?
|
| Cells, Cultured | 26 | 2018 | 19232 | 0.290 |
Why?
|
| Exocytosis | 4 | 2016 | 354 | 0.290 |
Why?
|
| Arachidonate 5-Lipoxygenase | 6 | 2005 | 144 | 0.290 |
Why?
|
| Signal Transduction | 17 | 2017 | 23398 | 0.290 |
Why?
|
| Immunoglobulin M | 4 | 2008 | 1537 | 0.280 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2011 | 4386 | 0.280 |
Why?
|
| Autocrine Communication | 4 | 2011 | 171 | 0.280 |
Why?
|
| Lymphocytes | 7 | 1997 | 2615 | 0.270 |
Why?
|
| SRS-A | 7 | 1989 | 156 | 0.270 |
Why?
|
| Tomography | 1 | 2008 | 389 | 0.270 |
Why?
|
| Receptors, Immunologic | 6 | 2019 | 1423 | 0.270 |
Why?
|
| Biological Assay | 2 | 2017 | 650 | 0.270 |
Why?
|
| Anti-Asthmatic Agents | 4 | 2007 | 536 | 0.270 |
Why?
|
| Membrane Proteins | 10 | 2018 | 7880 | 0.270 |
Why?
|
| Chemokine CCL19 | 2 | 2017 | 35 | 0.260 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 2005 | 12 | 0.260 |
Why?
|
| Microscopy, Fluorescence | 6 | 2017 | 2692 | 0.260 |
Why?
|
| Helminths | 3 | 2010 | 35 | 0.260 |
Why?
|
| Leishmania braziliensis | 1 | 2005 | 15 | 0.260 |
Why?
|
| Subcellular Fractions | 8 | 2015 | 545 | 0.260 |
Why?
|
| Biological Transport | 5 | 2016 | 2119 | 0.260 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 262 | 0.250 |
Why?
|
| Protein Transport | 6 | 2016 | 1988 | 0.250 |
Why?
|
| Chemotactic Factors | 3 | 1996 | 199 | 0.250 |
Why?
|
| Lung | 12 | 2017 | 9858 | 0.250 |
Why?
|
| Basophils | 4 | 2001 | 389 | 0.250 |
Why?
|
| U937 Cells | 2 | 2006 | 268 | 0.250 |
Why?
|
| Mice | 31 | 2019 | 81154 | 0.240 |
Why?
|
| Surgical Flaps | 1 | 2013 | 1629 | 0.240 |
Why?
|
| Prednisone | 4 | 2022 | 1574 | 0.240 |
Why?
|
| Cell Communication | 4 | 2014 | 1621 | 0.240 |
Why?
|
| HLA-DR Antigens | 5 | 1993 | 645 | 0.240 |
Why?
|
| Blotting, Western | 4 | 2013 | 5179 | 0.230 |
Why?
|
| Wuchereria bancrofti | 9 | 2001 | 20 | 0.230 |
Why?
|
| Th1 Cells | 1 | 2008 | 1057 | 0.230 |
Why?
|
| Chemokines | 3 | 2007 | 968 | 0.230 |
Why?
|
| Nitrobenzenes | 1 | 2002 | 65 | 0.220 |
Why?
|
| Chondro-4-Sulfatase | 5 | 1997 | 5 | 0.220 |
Why?
|
| Staining and Labeling | 5 | 2017 | 1098 | 0.210 |
Why?
|
| Extracellular Space | 3 | 2013 | 595 | 0.210 |
Why?
|
| Cell Movement | 12 | 2012 | 5216 | 0.210 |
Why?
|
| Skin Diseases | 5 | 2012 | 1066 | 0.210 |
Why?
|
| Prostaglandin D2 | 3 | 2018 | 122 | 0.210 |
Why?
|
| Leukotriene Antagonists | 4 | 2010 | 127 | 0.210 |
Why?
|
| Brefeldin A | 3 | 2008 | 72 | 0.200 |
Why?
|
| Fascioliasis | 1 | 2001 | 14 | 0.200 |
Why?
|
| Fasciola hepatica | 1 | 2001 | 15 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4033 | 0.200 |
Why?
|
| Antigens, CD | 6 | 2009 | 4026 | 0.200 |
Why?
|
| Strongyloidiasis | 3 | 2006 | 27 | 0.200 |
Why?
|
| Thrombosis | 1 | 2015 | 2968 | 0.200 |
Why?
|
| Immunity | 3 | 2015 | 1013 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2013 | 10940 | 0.190 |
Why?
|
| Immunomagnetic Separation | 1 | 2001 | 80 | 0.190 |
Why?
|
| Palmitic Acid | 2 | 2020 | 154 | 0.190 |
Why?
|
| DNA | 5 | 2022 | 7295 | 0.190 |
Why?
|
| Schistosomiasis mansoni | 2 | 2018 | 85 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 6 | 1996 | 1602 | 0.190 |
Why?
|
| Cell-Free System | 2 | 2012 | 344 | 0.190 |
Why?
|
| Transforming Growth Factor alpha | 6 | 1998 | 135 | 0.190 |
Why?
|
| Strongyloides stercoralis | 2 | 2006 | 23 | 0.180 |
Why?
|
| Allergens | 1 | 2007 | 1320 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2016 | 4556 | 0.180 |
Why?
|
| Proteins | 2 | 2014 | 6098 | 0.180 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2009 | 293 | 0.170 |
Why?
|
| Sulfatases | 3 | 1986 | 45 | 0.170 |
Why?
|
| Schistosoma | 1 | 2019 | 17 | 0.170 |
Why?
|
| Organ Specificity | 2 | 2017 | 2008 | 0.170 |
Why?
|
| Eosinophilic Granuloma | 1 | 2018 | 27 | 0.170 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 599 | 0.170 |
Why?
|
| Blood Proteins | 7 | 2009 | 1125 | 0.160 |
Why?
|
| Recombinant Proteins | 6 | 2018 | 6620 | 0.160 |
Why?
|
| Nematode Infections | 2 | 2000 | 22 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 9731 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 2123 | 0.160 |
Why?
|
| Immunomodulation | 2 | 2014 | 541 | 0.160 |
Why?
|
| Aniline Compounds | 3 | 2013 | 986 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8430 | 0.150 |
Why?
|
| Prostaglandins | 4 | 1992 | 405 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 4 | 1996 | 573 | 0.150 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 18027 | 0.150 |
Why?
|
| RNA | 4 | 2003 | 2748 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1991 | 546 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2009 | 1789 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2014 | 1581 | 0.140 |
Why?
|
| Elephantiasis, Filarial | 2 | 2001 | 29 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 354 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2018 | 3749 | 0.140 |
Why?
|
| Bronchi | 5 | 2000 | 840 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 5 | 2019 | 2006 | 0.140 |
Why?
|
| Plasma Cells | 1 | 2020 | 593 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.140 |
Why?
|
| Protozoan Infections | 1 | 1996 | 39 | 0.140 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 686 | 0.140 |
Why?
|
| Mouth Neoplasms | 3 | 1999 | 601 | 0.140 |
Why?
|
| Mice, Inbred C3H | 4 | 2007 | 964 | 0.140 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2005 | 192 | 0.140 |
Why?
|
| Certification | 1 | 1999 | 423 | 0.140 |
Why?
|
| Membrane Lipids | 2 | 1997 | 251 | 0.140 |
Why?
|
| Dirofilaria immitis | 2 | 1989 | 9 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2001 | 850 | 0.130 |
Why?
|
| Antiprotozoal Agents | 1 | 1996 | 86 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2002 | 1318 | 0.130 |
Why?
|
| Qa-SNARE Proteins | 1 | 2015 | 54 | 0.130 |
Why?
|
| Leukotriene B4 | 4 | 2002 | 294 | 0.130 |
Why?
|
| Hematologic Tests | 1 | 2016 | 240 | 0.130 |
Why?
|
| Dinoprostone | 2 | 2002 | 601 | 0.130 |
Why?
|
| Adoptive Transfer | 2 | 2008 | 844 | 0.130 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2018 | 300 | 0.130 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2015 | 132 | 0.130 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 693 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2002 | 1800 | 0.120 |
Why?
|
| Receptors, IgG | 3 | 2012 | 581 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4665 | 0.120 |
Why?
|
| Biological Products | 1 | 2023 | 859 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2002 | 2281 | 0.120 |
Why?
|
| Peptide Hydrolases | 2 | 2015 | 633 | 0.120 |
Why?
|
| Ivermectin | 2 | 1993 | 42 | 0.120 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3205 | 0.120 |
Why?
|
| Immunoglobulin G | 4 | 2020 | 4561 | 0.120 |
Why?
|
| Dyspnea | 1 | 2002 | 1303 | 0.120 |
Why?
|
| Genes | 4 | 1994 | 1893 | 0.120 |
Why?
|
| Macrophages | 6 | 2011 | 5651 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2018 | 775 | 0.120 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2865 | 0.110 |
Why?
|
| Xanthenes | 1 | 2013 | 73 | 0.110 |
Why?
|
| Chemokine CCL21 | 1 | 2013 | 51 | 0.110 |
Why?
|
| Parasitic Diseases | 2 | 1992 | 75 | 0.110 |
Why?
|
| Stem Cell Factor | 1 | 2014 | 219 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 594 | 0.110 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1993 | 66 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 1995 | 3144 | 0.110 |
Why?
|
| Interleukin-13 | 3 | 2015 | 389 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2018 | 552 | 0.110 |
Why?
|
| Phlebotomy | 1 | 2014 | 141 | 0.110 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1102 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2002 | 1938 | 0.110 |
Why?
|
| RNA, Messenger | 14 | 2003 | 13028 | 0.110 |
Why?
|
| Leukotriene D4 | 2 | 2002 | 38 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2002 | 156 | 0.110 |
Why?
|
| Blood Group Antigens | 1 | 1994 | 180 | 0.110 |
Why?
|
| Pertussis Toxin | 2 | 2002 | 178 | 0.110 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 722 | 0.110 |
Why?
|
| Biological Transport, Active | 2 | 2009 | 349 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 1997 | 595 | 0.100 |
Why?
|
| Candida albicans | 1 | 2015 | 394 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 375 | 0.100 |
Why?
|
| Mucins | 1 | 2015 | 564 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1117 | 0.100 |
Why?
|
| Interleukin-12 | 3 | 2003 | 577 | 0.100 |
Why?
|
| Esthetics | 1 | 2013 | 305 | 0.100 |
Why?
|
| Male | 58 | 2021 | 349776 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 2 | 2012 | 1171 | 0.100 |
Why?
|
| Meningitis | 1 | 1993 | 216 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 2 | 2008 | 999 | 0.100 |
Why?
|
| Fever of Unknown Origin | 1 | 1992 | 93 | 0.100 |
Why?
|
| Quinolines | 2 | 2010 | 732 | 0.100 |
Why?
|
| Carbodiimides | 1 | 2011 | 11 | 0.100 |
Why?
|
| Biological Factors | 2 | 2023 | 164 | 0.100 |
Why?
|
| Virus Diseases | 2 | 2021 | 711 | 0.100 |
Why?
|
| Osmium | 1 | 2011 | 19 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 1996 | 707 | 0.100 |
Why?
|
| Angioedema | 3 | 2009 | 187 | 0.100 |
Why?
|
| Peroxidases | 3 | 1997 | 138 | 0.100 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2018 | 781 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2011 | 69 | 0.100 |
Why?
|
| Sinusitis | 2 | 2015 | 921 | 0.100 |
Why?
|
| Protein Kinase C | 4 | 1997 | 1227 | 0.090 |
Why?
|
| Diethylcarbamazine | 6 | 1990 | 23 | 0.090 |
Why?
|
| Benzamides | 2 | 2014 | 1383 | 0.090 |
Why?
|
| Azo Compounds | 1 | 2011 | 113 | 0.090 |
Why?
|
| Aldehyde Oxidase | 1 | 2010 | 4 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2008 | 4422 | 0.090 |
Why?
|
| X Chromosome | 1 | 1994 | 814 | 0.090 |
Why?
|
| Leptin | 1 | 2018 | 1600 | 0.090 |
Why?
|
| Homeostasis | 2 | 2020 | 3337 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2018 | 1771 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1411 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 780 | 0.090 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 371 | 0.090 |
Why?
|
| Macrophages, Alveolar | 1 | 1992 | 407 | 0.090 |
Why?
|
| Aspirin | 3 | 2001 | 3283 | 0.090 |
Why?
|
| Staphylococcus aureus | 3 | 2015 | 1453 | 0.090 |
Why?
|
| Boron Compounds | 1 | 2011 | 175 | 0.090 |
Why?
|
| Adult | 45 | 2021 | 213889 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2006 | 1574 | 0.090 |
Why?
|
| Cartilage | 1 | 2013 | 818 | 0.080 |
Why?
|
| Leukocyte Disorders | 1 | 2009 | 12 | 0.080 |
Why?
|
| Magnetics | 1 | 2012 | 604 | 0.080 |
Why?
|
| Oxazines | 1 | 2011 | 298 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1263 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2011 | 166 | 0.080 |
Why?
|
| Sulfides | 1 | 2010 | 165 | 0.080 |
Why?
|
| Retroviridae Proteins | 1 | 1989 | 98 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 124 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 9 | 2012 | 9272 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 814 | 0.080 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2001 | 94 | 0.080 |
Why?
|
| Immunity, Cellular | 2 | 2010 | 1608 | 0.080 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2011 | 247 | 0.080 |
Why?
|
| Platelet Aggregation | 1 | 1992 | 798 | 0.080 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3769 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 2001 | 4459 | 0.080 |
Why?
|
| Ovalbumin | 2 | 2007 | 719 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2017 | 880 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1077 | 0.080 |
Why?
|
| Acetates | 1 | 2010 | 310 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1996 | 1222 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2010 | 415 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2019 | 85 | 0.080 |
Why?
|
| Babesiosis | 1 | 1989 | 92 | 0.080 |
Why?
|
| Calcium | 3 | 2013 | 5755 | 0.080 |
Why?
|
| Cell Differentiation | 5 | 2015 | 11478 | 0.080 |
Why?
|
| Ammonium Chloride | 1 | 2007 | 73 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2013 | 797 | 0.080 |
Why?
|
| Receptors, IgE | 1 | 2010 | 389 | 0.080 |
Why?
|
| Fluorescent Dyes | 3 | 2000 | 1903 | 0.080 |
Why?
|
| Genistein | 2 | 1998 | 88 | 0.080 |
Why?
|
| Giardia | 1 | 1987 | 7 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1580 | 0.080 |
Why?
|
| Rhinitis | 1 | 2015 | 690 | 0.080 |
Why?
|
| Receptors, Interleukin-4 | 2 | 2006 | 65 | 0.080 |
Why?
|
| Splenectomy | 1 | 1989 | 394 | 0.080 |
Why?
|
| Gastroenteritis | 1 | 2009 | 245 | 0.080 |
Why?
|
| Respiratory System | 1 | 2011 | 557 | 0.070 |
Why?
|
| Female | 48 | 2021 | 380020 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 3706 | 0.070 |
Why?
|
| Proteoglycans | 2 | 2009 | 837 | 0.070 |
Why?
|
| Pleurisy | 4 | 2006 | 53 | 0.070 |
Why?
|
| Cell Survival | 6 | 2015 | 5881 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13691 | 0.070 |
Why?
|
| Paracrine Communication | 2 | 2011 | 278 | 0.070 |
Why?
|
| Antigens | 5 | 1982 | 1466 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 1997 | 7719 | 0.070 |
Why?
|
| Type C Phospholipases | 3 | 1996 | 292 | 0.070 |
Why?
|
| Glucocorticoids | 3 | 2017 | 2107 | 0.070 |
Why?
|
| Phosphatidylinositols | 4 | 1989 | 291 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 906 | 0.070 |
Why?
|
| Mesoderm | 1 | 1989 | 686 | 0.070 |
Why?
|
| Liver Diseases | 2 | 2007 | 1253 | 0.070 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2006 | 13 | 0.070 |
Why?
|
| Antibodies | 3 | 2005 | 2459 | 0.070 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 12066 | 0.070 |
Why?
|
| Adipocytes | 1 | 2013 | 1182 | 0.070 |
Why?
|
| Bromeliaceae | 1 | 2005 | 1 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1524 | 0.070 |
Why?
|
| Immunoglobulins | 3 | 1997 | 881 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 4 | 1984 | 337 | 0.070 |
Why?
|
| Piperazines | 2 | 2014 | 2487 | 0.070 |
Why?
|
| Interleukin-3 | 3 | 1998 | 444 | 0.070 |
Why?
|
| Recurrence | 3 | 2017 | 8337 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 424 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5532 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 674 | 0.070 |
Why?
|
| Uridine | 2 | 2003 | 146 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2009 | 1854 | 0.070 |
Why?
|
| Pacific Islands | 5 | 1992 | 50 | 0.070 |
Why?
|
| Actins | 1 | 2013 | 2121 | 0.070 |
Why?
|
| Cricetinae | 6 | 1999 | 2475 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 277 | 0.070 |
Why?
|
| Antimony Sodium Gluconate | 1 | 2005 | 10 | 0.070 |
Why?
|
| Zoonoses | 2 | 1984 | 183 | 0.060 |
Why?
|
| Biomedical Research | 3 | 2021 | 3308 | 0.060 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2018 | 109 | 0.060 |
Why?
|
| Eosinophil Peroxidase | 3 | 2015 | 20 | 0.060 |
Why?
|
| Avidin | 1 | 2005 | 44 | 0.060 |
Why?
|
| Hypersensitivity, Delayed | 3 | 1980 | 484 | 0.060 |
Why?
|
| SEER Program | 1 | 2010 | 1507 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 1989 | 635 | 0.060 |
Why?
|
| Trypanocidal Agents | 1 | 2005 | 38 | 0.060 |
Why?
|
| Purpura | 1 | 2006 | 122 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 3794 | 0.060 |
Why?
|
| Syndrome | 8 | 2006 | 3249 | 0.060 |
Why?
|
| Histamine Release | 2 | 1995 | 142 | 0.060 |
Why?
|
| Base Sequence | 10 | 1997 | 12798 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2291 | 0.060 |
Why?
|
| Biopsy | 5 | 2006 | 6750 | 0.060 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2006 | 225 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 20948 | 0.060 |
Why?
|
| Molecular Weight | 5 | 1989 | 2253 | 0.060 |
Why?
|
| Histamine | 5 | 1995 | 507 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 811 | 0.060 |
Why?
|
| Nose Diseases | 1 | 2005 | 79 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 960 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2014 | 2945 | 0.060 |
Why?
|
| Cystic Fibrosis | 2 | 2004 | 1178 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2014 | 2951 | 0.060 |
Why?
|
| Kinetics | 9 | 1992 | 6476 | 0.060 |
Why?
|
| Esterification | 3 | 1989 | 36 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2009 | 739 | 0.060 |
Why?
|
| Lipoxygenase | 1 | 1983 | 74 | 0.060 |
Why?
|
| Endothelium | 3 | 1993 | 777 | 0.060 |
Why?
|
| Anti-Allergic Agents | 1 | 2005 | 141 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2009 | 12954 | 0.060 |
Why?
|
| Complement System Proteins | 3 | 1997 | 796 | 0.060 |
Why?
|
| Bombesin | 1 | 2003 | 34 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1962 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 4033 | 0.060 |
Why?
|
| Gels | 1 | 2005 | 425 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14563 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 717 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3530 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2015 | 4216 | 0.060 |
Why?
|
| Middle Aged | 29 | 2021 | 213241 | 0.060 |
Why?
|
| Microbiological Techniques | 1 | 2004 | 102 | 0.060 |
Why?
|
| Reoperation | 1 | 2013 | 4200 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1400 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2003 | 274 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 2 | 2002 | 612 | 0.060 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2022 | 13 | 0.060 |
Why?
|
| Gene Expression | 2 | 2015 | 7793 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 1999 | 18107 | 0.060 |
Why?
|
| DNA Primers | 3 | 1996 | 2891 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14714 | 0.050 |
Why?
|
| Nasal Obstruction | 1 | 2005 | 151 | 0.050 |
Why?
|
| Agammaglobulinemia | 1 | 1984 | 167 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2274 | 0.050 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 3391 | 0.050 |
Why?
|
| Acetophenones | 1 | 2002 | 48 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 1952 | 0.050 |
Why?
|
| Carbon Radioisotopes | 2 | 1998 | 577 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2001 | 5524 | 0.050 |
Why?
|
| Leukotriene E4 | 1 | 2002 | 79 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1894 | 0.050 |
Why?
|
| Japanese Encephalitis Vaccines | 1 | 2001 | 6 | 0.050 |
Why?
|
| Myocardium | 1 | 2015 | 4775 | 0.050 |
Why?
|
| Electrons | 1 | 2003 | 268 | 0.050 |
Why?
|
| Sputum | 1 | 2004 | 476 | 0.050 |
Why?
|
| Hepatitis A Vaccines | 1 | 2001 | 29 | 0.050 |
Why?
|
| Antigens, Helminth | 1 | 2001 | 64 | 0.050 |
Why?
|
| Chemokine CCL24 | 1 | 2001 | 8 | 0.050 |
Why?
|
| Rabies Vaccines | 1 | 2001 | 31 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2013 | 8436 | 0.050 |
Why?
|
| Tritium | 3 | 1992 | 745 | 0.050 |
Why?
|
| Indomethacin | 2 | 2001 | 332 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 8637 | 0.050 |
Why?
|
| Propionates | 1 | 2002 | 169 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2005 | 471 | 0.050 |
Why?
|
| Fever | 1 | 1989 | 1616 | 0.050 |
Why?
|
| Ligands | 1 | 2009 | 3281 | 0.050 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2001 | 39 | 0.050 |
Why?
|
| Yellow Fever Vaccine | 1 | 2001 | 37 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2001 | 50 | 0.050 |
Why?
|
| United States | 9 | 2018 | 69859 | 0.050 |
Why?
|
| Autoradiography | 3 | 2000 | 745 | 0.050 |
Why?
|
| Headache | 1 | 1989 | 1224 | 0.050 |
Why?
|
| Mesocricetus | 2 | 1999 | 252 | 0.050 |
Why?
|
| Reference Values | 5 | 1998 | 4974 | 0.050 |
Why?
|
| HIV | 1 | 1989 | 1604 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 1996 | 1386 | 0.050 |
Why?
|
| Gerbillinae | 2 | 1992 | 89 | 0.050 |
Why?
|
| Africa, Western | 1 | 2001 | 154 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 6487 | 0.050 |
Why?
|
| Nose | 1 | 2005 | 509 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2000 | 1454 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2002 | 1728 | 0.050 |
Why?
|
| Cestode Infections | 1 | 2000 | 6 | 0.050 |
Why?
|
| Cytosol | 2 | 1998 | 901 | 0.050 |
Why?
|
| Pulmonary Atelectasis | 1 | 2002 | 145 | 0.050 |
Why?
|
| Trematode Infections | 1 | 2000 | 5 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2002 | 216 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2011 | 1591 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 1992 | 1904 | 0.050 |
Why?
|
| Biotinylation | 1 | 2000 | 179 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 320 | 0.050 |
Why?
|
| Fibroblasts | 2 | 1995 | 4162 | 0.050 |
Why?
|
| Protein Binding | 3 | 2006 | 9377 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19894 | 0.040 |
Why?
|
| Ribosomes | 1 | 2003 | 500 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2001 | 310 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 5986 | 0.040 |
Why?
|
| Phospholipids | 3 | 1988 | 784 | 0.040 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2003 | 305 | 0.040 |
Why?
|
| Rabbits | 3 | 2002 | 4894 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 12209 | 0.040 |
Why?
|
| Lectins | 2 | 1993 | 513 | 0.040 |
Why?
|
| E-Selectin | 2 | 1992 | 579 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2001 | 236 | 0.040 |
Why?
|
| Hydantoins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Lung Diseases | 2 | 2007 | 1887 | 0.040 |
Why?
|
| Aged | 19 | 2021 | 163178 | 0.040 |
Why?
|
| Adolescent | 17 | 2013 | 85729 | 0.040 |
Why?
|
| Bacterial Proteins | 3 | 2003 | 3850 | 0.040 |
Why?
|
| Palmitic Acids | 2 | 1989 | 54 | 0.040 |
Why?
|
| Fatty Acids | 1 | 1987 | 1809 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 269 | 0.040 |
Why?
|
| Schistosomiasis | 1 | 1979 | 62 | 0.040 |
Why?
|
| Quinones | 1 | 1998 | 76 | 0.040 |
Why?
|
| Rifabutin | 1 | 1998 | 52 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 187 | 0.040 |
Why?
|
| Skin Tests | 1 | 2000 | 613 | 0.040 |
Why?
|
| Amine Oxidase (Copper-Containing) | 2 | 1995 | 41 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1998 | 2453 | 0.040 |
Why?
|
| Feces | 2 | 2001 | 1397 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2007 | 4221 | 0.040 |
Why?
|
| Diglycerides | 2 | 1991 | 176 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 1997 | 6170 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2018 | 12020 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2950 | 0.040 |
Why?
|
| Pericytes | 1 | 2001 | 293 | 0.040 |
Why?
|
| Education | 1 | 2001 | 543 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 894 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2001 | 690 | 0.040 |
Why?
|
| Benzoquinones | 1 | 1998 | 201 | 0.040 |
Why?
|
| Phospholipases A2 | 1 | 1998 | 203 | 0.040 |
Why?
|
| Benzophenanthridines | 1 | 1997 | 27 | 0.040 |
Why?
|
| Blepharitis | 2 | 1995 | 36 | 0.040 |
Why?
|
| HIV-1 | 1 | 1995 | 6939 | 0.040 |
Why?
|
| Phenanthridines | 1 | 1997 | 51 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9648 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 1998 | 457 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 334 | 0.040 |
Why?
|
| Brugia malayi | 1 | 1997 | 5 | 0.040 |
Why?
|
| Adenosine Diphosphate | 2 | 2015 | 425 | 0.040 |
Why?
|
| Complement C5 | 2 | 1995 | 112 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 429 | 0.040 |
Why?
|
| Pericardium | 1 | 2002 | 667 | 0.040 |
Why?
|
| Wound Healing | 3 | 1997 | 2776 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1997 | 4320 | 0.040 |
Why?
|
| Lymphedema | 1 | 1984 | 534 | 0.040 |
Why?
|
| Cromolyn Sodium | 1 | 1997 | 87 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2018 | 441 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2000 | 551 | 0.040 |
Why?
|
| Dogs | 2 | 2010 | 3911 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 1998 | 319 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1619 | 0.040 |
Why?
|
| Mucoproteins | 1 | 1996 | 50 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 960 | 0.040 |
Why?
|
| Esters | 2 | 1988 | 210 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2002 | 834 | 0.040 |
Why?
|
| RNA, Small Nuclear | 2 | 1987 | 64 | 0.040 |
Why?
|
| Isoflavones | 1 | 1997 | 139 | 0.040 |
Why?
|
| Time Factors | 14 | 2005 | 40038 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1996 | 143 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1996 | 121 | 0.030 |
Why?
|
| Alkaloids | 1 | 1997 | 190 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2002 | 861 | 0.030 |
Why?
|
| Genes, gag | 1 | 1995 | 61 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63042 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 426 | 0.030 |
Why?
|
| Structure-Activity Relationship | 4 | 2012 | 3128 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1993 | 1581 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 667 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2015 | 43 | 0.030 |
Why?
|
| Androstadienes | 1 | 1997 | 345 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 771 | 0.030 |
Why?
|
| Phagosomes | 1 | 2017 | 193 | 0.030 |
Why?
|
| Gold | 2 | 2000 | 485 | 0.030 |
Why?
|
| HIV Core Protein p24 | 1 | 1995 | 256 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 1996 | 96 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1995 | 74 | 0.030 |
Why?
|
| Growth | 1 | 1997 | 376 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1995 | 109 | 0.030 |
Why?
|
| Amino Acid Sequence | 5 | 1999 | 13809 | 0.030 |
Why?
|
| Liver | 3 | 2018 | 7479 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 1997 | 294 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1995 | 114 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2217 | 0.030 |
Why?
|
| Young Adult | 4 | 2018 | 56392 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 2988 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3445 | 0.030 |
Why?
|
| Albuterol | 1 | 1995 | 208 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 1995 | 3038 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2000 | 971 | 0.030 |
Why?
|
| Receptors, Complement | 3 | 1995 | 264 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2001 | 1503 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1997 | 2050 | 0.030 |
Why?
|
| Chlorides | 2 | 1994 | 667 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2007 | 2789 | 0.030 |
Why?
|
| Superoxides | 2 | 1995 | 387 | 0.030 |
Why?
|
| Placebos | 1 | 2018 | 1674 | 0.030 |
Why?
|
| Canada | 1 | 1999 | 2064 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 1996 | 969 | 0.030 |
Why?
|
| Thiabendazole | 1 | 1993 | 3 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2017 | 329 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 1994 | 95 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1995 | 346 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 29052 | 0.030 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2969 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1076 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1996 | 757 | 0.030 |
Why?
|
| Skin | 5 | 2006 | 4372 | 0.030 |
Why?
|
| Rats | 7 | 2010 | 24250 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2018 | 77410 | 0.030 |
Why?
|
| Binding Sites | 3 | 1997 | 6111 | 0.030 |
Why?
|
| Albendazole | 1 | 1993 | 33 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
| Monokines | 1 | 1993 | 79 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1781 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2015 | 229 | 0.030 |
Why?
|
| Wounds, Penetrating | 1 | 1996 | 307 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2015 | 2509 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 1582 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1997 | 2839 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 21824 | 0.030 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2012 | 10 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39001 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1996 | 432 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 709 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1994 | 211 | 0.030 |
Why?
|
| Databases as Topic | 2 | 2005 | 474 | 0.030 |
Why?
|
| Epithelium | 5 | 1997 | 1679 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 705 | 0.030 |
Why?
|
| Nasal Polyps | 2 | 1996 | 360 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2963 | 0.030 |
Why?
|
| Models, Biological | 2 | 2007 | 9582 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6311 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1995 | 502 | 0.030 |
Why?
|
| Methysergide | 1 | 1991 | 28 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2002 | 1970 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2327 | 0.030 |
Why?
|
| Eyelids | 1 | 1994 | 264 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 1992 | 111 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1374 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1994 | 1159 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1993 | 192 | 0.030 |
Why?
|
| Quality of Life | 1 | 2013 | 12788 | 0.030 |
Why?
|
| HIV Infections | 2 | 1995 | 16715 | 0.030 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1992 | 226 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1993 | 319 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 1993 | 275 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 23327 | 0.030 |
Why?
|
| Erythrocyte Membrane | 2 | 1984 | 442 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2011 | 203 | 0.020 |
Why?
|
| Saliva | 1 | 1996 | 809 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 2384 | 0.020 |
Why?
|
| Fibronectins | 1 | 1995 | 726 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1642 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1991 | 104 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2012 | 349 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 72252 | 0.020 |
Why?
|
| Arthritis | 1 | 1996 | 661 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15281 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1991 | 433 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 250 | 0.020 |
Why?
|
| Lipocalins | 1 | 2011 | 170 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1992 | 408 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1990 | 223 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 1990 | 152 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2002 | 2119 | 0.020 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1991 | 140 | 0.020 |
Why?
|
| Radiography | 1 | 2002 | 7010 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1994 | 811 | 0.020 |
Why?
|
| Rats, Inbred BB | 1 | 2010 | 31 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2931 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 40545 | 0.020 |
Why?
|
| Chemokine CCL17 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Iodopyracet | 1 | 1969 | 2 | 0.020 |
Why?
|
| Pleura | 1 | 1991 | 235 | 0.020 |
Why?
|
| Piperidines | 1 | 2018 | 1601 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1997 | 1950 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 762 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 821 | 0.020 |
Why?
|
| Leukapheresis | 1 | 1990 | 131 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1989 | 39 | 0.020 |
Why?
|
| Publishing | 1 | 2017 | 833 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1993 | 927 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1989 | 85 | 0.020 |
Why?
|
| Lipoxins | 1 | 1992 | 412 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2017 | 821 | 0.020 |
Why?
|
| Pain | 1 | 2005 | 4987 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1989 | 70 | 0.020 |
Why?
|
| Quinine | 1 | 1989 | 54 | 0.020 |
Why?
|
| Keratins | 1 | 1991 | 515 | 0.020 |
Why?
|
| Babesia | 1 | 1989 | 28 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1998 | 2440 | 0.020 |
Why?
|
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| Ticks | 1 | 1989 | 70 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2256 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1989 | 221 | 0.020 |
Why?
|
| Haplorhini | 1 | 2010 | 548 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3583 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1990 | 211 | 0.020 |
Why?
|
| Collodion | 1 | 1988 | 34 | 0.020 |
Why?
|
| Complement C8 | 1 | 1988 | 11 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 139 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1994 | 1586 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1991 | 394 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1995 | 2226 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 660 | 0.020 |
Why?
|
| Child | 14 | 2009 | 77637 | 0.020 |
Why?
|
| Gingiva | 1 | 1991 | 380 | 0.020 |
Why?
|
| Hematopoiesis | 2 | 2011 | 2073 | 0.020 |
Why?
|
| Tryptases | 1 | 2009 | 190 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1999 | 2576 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1989 | 157 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2009 | 289 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1988 | 70 | 0.020 |
Why?
|
| Extracellular Matrix | 2 | 1993 | 1743 | 0.020 |
Why?
|
| Calcimycin | 2 | 1988 | 222 | 0.020 |
Why?
|
| Endocytosis | 3 | 1990 | 985 | 0.020 |
Why?
|
| Urticaria | 1 | 2009 | 150 | 0.020 |
Why?
|
| Hemolysis | 2 | 1995 | 420 | 0.020 |
Why?
|
| Exons | 1 | 1994 | 2438 | 0.020 |
Why?
|
| Filtration | 1 | 1988 | 233 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4749 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2010 | 370 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1999 | 3740 | 0.020 |
Why?
|
| Jejunum | 1 | 2009 | 480 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1969 | 488 | 0.020 |
Why?
|
| RNA Polymerase III | 1 | 1987 | 51 | 0.020 |
Why?
|
| Crohn Disease | 2 | 1995 | 2304 | 0.020 |
Why?
|
| Growth Substances | 1 | 1989 | 784 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1988 | 670 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1826 | 0.020 |
Why?
|
| Airway Resistance | 2 | 1993 | 404 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 462 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 2681 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 788 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 549 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 2003 | 694 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15142 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1986 | 4009 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1987 | 379 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1997 | 3510 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1586 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 2429 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4737 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2480 | 0.020 |
Why?
|
| Prostaglandins B | 1 | 1985 | 5 | 0.020 |
Why?
|
| p-Chloromercuribenzoic Acid | 1 | 1984 | 1 | 0.020 |
Why?
|
| Chloromercuribenzoates | 1 | 1984 | 5 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 895 | 0.020 |
Why?
|
| Prostaglandins A | 1 | 1985 | 16 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1811 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2009 | 772 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1987 | 371 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1997 | 3389 | 0.020 |
Why?
|
| Malta | 1 | 1984 | 6 | 0.020 |
Why?
|
| Libya | 1 | 1984 | 9 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2005 | 143 | 0.020 |
Why?
|
| Oklahoma | 1 | 1984 | 37 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1984 | 46 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1546 | 0.020 |
Why?
|
| Interleukins | 1 | 1989 | 791 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1991 | 2029 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2009 | 659 | 0.020 |
Why?
|
| World Health Organization | 1 | 2010 | 1317 | 0.020 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 1983 | 19 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1985 | 410 | 0.010 |
Why?
|
| Myoglobin | 1 | 1984 | 160 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 4463 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1984 | 81 | 0.010 |
Why?
|
| Benzopyrenes | 1 | 1983 | 5 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3772 | 0.010 |
Why?
|
| Administration, Inhalation | 2 | 1997 | 1105 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13404 | 0.010 |
Why?
|
| Complement C3 | 2 | 1982 | 461 | 0.010 |
Why?
|
| Globins | 1 | 1984 | 416 | 0.010 |
Why?
|
| Peptides | 2 | 2012 | 4406 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1983 | 174 | 0.010 |
Why?
|
| Complement Activating Enzymes | 1 | 1982 | 28 | 0.010 |
Why?
|
| Child, Preschool | 8 | 2001 | 40964 | 0.010 |
Why?
|
| Complement C3-C5 Convertases | 1 | 1982 | 37 | 0.010 |
Why?
|
| Apoptosis | 2 | 1996 | 9718 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1994 | 1382 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15067 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7172 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4440 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 909 | 0.010 |
Why?
|
| Organoids | 1 | 1988 | 701 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2002 | 448 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2617 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1997 | 6535 | 0.010 |
Why?
|
| Complement Activation | 1 | 1984 | 453 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2003 | 231 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 2004 | 642 | 0.010 |
Why?
|
| Papio | 1 | 2003 | 656 | 0.010 |
Why?
|
| Immune Sera | 1 | 1982 | 641 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 57744 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2002 | 190 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1678 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 1984 | 261 | 0.010 |
Why?
|
| R-SNARE Proteins | 1 | 2001 | 74 | 0.010 |
Why?
|
| Crystallography | 1 | 1980 | 111 | 0.010 |
Why?
|
| Parasitemia | 1 | 2001 | 173 | 0.010 |
Why?
|
| Intradermal Tests | 1 | 1980 | 44 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1851 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1992 | 2707 | 0.010 |
Why?
|
| Shock, Septic | 2 | 2002 | 775 | 0.010 |
Why?
|
| Venules | 1 | 2001 | 165 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1983 | 419 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1987 | 1344 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 847 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1989 | 1400 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1980 | 363 | 0.010 |
Why?
|
| Occupations | 1 | 1982 | 517 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2001 | 163 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2002 | 207 | 0.010 |
Why?
|
| Cephalosporins | 1 | 2000 | 203 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 2002 | 220 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8939 | 0.010 |
Why?
|
| Niridazole | 1 | 1979 | 1 | 0.010 |
Why?
|
| Neoplasms | 2 | 2006 | 21675 | 0.010 |
Why?
|
| Cattle | 2 | 2001 | 3917 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 694 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1981 | 207 | 0.010 |
Why?
|
| Streptodornase and Streptokinase | 1 | 1978 | 8 | 0.010 |
Why?
|
| Puromycin | 1 | 1978 | 44 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9440 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2359 | 0.010 |
Why?
|
| Tuberculin | 1 | 1978 | 66 | 0.010 |
Why?
|
| SOX9 Transcription Factor | 1 | 1999 | 146 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10179 | 0.010 |
Why?
|
| Amino Acids | 1 | 1984 | 1733 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 2542 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2914 | 0.010 |
Why?
|
| Epitopes | 2 | 1982 | 2570 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1978 | 219 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2001 | 565 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 675 | 0.010 |
Why?
|
| Penicillins | 1 | 2000 | 380 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 199 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 11729 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 686 | 0.010 |
Why?
|
| Triglycerides | 1 | 1985 | 2453 | 0.010 |
Why?
|
| Infant | 4 | 2001 | 35122 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 893 | 0.010 |
Why?
|
| Destrin | 1 | 1997 | 9 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 281 | 0.010 |
Why?
|
| Glia Maturation Factor | 1 | 1997 | 15 | 0.010 |
Why?
|
| COS Cells | 1 | 1999 | 1161 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2007 | 21733 | 0.010 |
Why?
|
| Actin Depolymerizing Factors | 1 | 1997 | 43 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1996 | 170 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 424 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 1978 | 319 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1980 | 1369 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 7908 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1978 | 1162 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 1996 | 193 | 0.010 |
Why?
|
| Periodicity | 1 | 1978 | 364 | 0.010 |
Why?
|
| Complement C7 | 1 | 1995 | 17 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 3000 | 0.010 |
Why?
|
| Larva | 1 | 1997 | 515 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1995 | 222 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1996 | 368 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1988 | 5021 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 29777 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1994 | 62 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1996 | 229 | 0.010 |
Why?
|
| Trypsin | 1 | 1995 | 511 | 0.010 |
Why?
|
| Cell Line | 4 | 1993 | 15993 | 0.010 |
Why?
|
| Cell Division | 2 | 1996 | 4568 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3712 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1995 | 420 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1995 | 241 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1979 | 1402 | 0.010 |
Why?
|
| Rhodamines | 1 | 1994 | 182 | 0.010 |
Why?
|
| Theophylline | 1 | 1993 | 132 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 1993 | 129 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1993 | 123 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2002 | 1155 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1993 | 227 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1783 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1993 | 233 | 0.010 |
Why?
|
| Polylysine | 1 | 1993 | 133 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 148 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1982 | 2455 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 6363 | 0.010 |
Why?
|
| Cations | 1 | 1993 | 232 | 0.010 |
Why?
|
| Xenopus laevis | 2 | 1987 | 956 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1997 | 3690 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1990 | 5264 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 803 | 0.010 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1991 | 8 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1996 | 9139 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 2000 | 884 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2003 | 25609 | 0.010 |
Why?
|
| Pregnancy | 1 | 1993 | 29140 | 0.010 |
Why?
|
| Fluorescence | 1 | 1994 | 752 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1997 | 1152 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 1143 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1990 | 62 | 0.010 |
Why?
|
| Cluster Headache | 1 | 1991 | 54 | 0.010 |
Why?
|
| Galectin 3 | 1 | 1993 | 228 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1994 | 645 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 8316 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 1157 | 0.010 |
Why?
|
| Body Height | 1 | 1997 | 1579 | 0.010 |
Why?
|
| Complement C4 | 2 | 1982 | 257 | 0.010 |
Why?
|
| Phenolphthaleins | 1 | 1969 | 5 | 0.010 |
Why?
|
| Aminohippuric Acids | 1 | 1969 | 9 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1969 | 90 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.010 |
Why?
|
| Aerosols | 2 | 1983 | 623 | 0.010 |
Why?
|
| Propranolol | 1 | 1991 | 502 | 0.010 |
Why?
|
| Serotonin | 1 | 1994 | 1017 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2796 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1997 | 1826 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13273 | 0.010 |
Why?
|
| Vaccination | 1 | 2001 | 3275 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4931 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1999 | 5445 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 719 | 0.010 |
Why?
|
| Plasma Exchange | 1 | 1990 | 152 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4189 | 0.010 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1989 | 188 | 0.010 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 1989 | 90 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1989 | 263 | 0.010 |
Why?
|
| Complement C5a | 1 | 1989 | 107 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1991 | 367 | 0.010 |
Why?
|
| Glucose | 1 | 2001 | 4398 | 0.010 |
Why?
|
| Sepsis | 1 | 2002 | 2593 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2002 | 3113 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 1837 | 0.010 |
Why?
|
| Blood Volume | 1 | 1990 | 565 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1998 | 2927 | 0.000 |
Why?
|
| X-Ray Diffraction | 1 | 1988 | 420 | 0.000 |
Why?
|
| DNA Polymerase I | 1 | 1987 | 38 | 0.000 |
Why?
|
| Sex Factors | 1 | 2001 | 10394 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 769 | 0.000 |
Why?
|
| Acute Disease | 1 | 1978 | 7150 | 0.000 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 1986 | 9 | 0.000 |
Why?
|
| Receptors, Histamine H2 | 1 | 1986 | 18 | 0.000 |
Why?
|
| Peroxidase | 1 | 1990 | 611 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1986 | 347 | 0.000 |
Why?
|
| Fishes | 1 | 1969 | 569 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20121 | 0.000 |
Why?
|
| Melanoma | 1 | 1985 | 5508 | 0.000 |
Why?
|
| Carrier State | 1 | 1989 | 518 | 0.000 |
Why?
|
| Physical Examination | 1 | 1992 | 1235 | 0.000 |
Why?
|
| Virulence | 1 | 1989 | 1328 | 0.000 |
Why?
|
| Intestines | 1 | 1995 | 1923 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4803 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1989 | 771 | 0.000 |
Why?
|
| Perfusion | 1 | 1969 | 1359 | 0.000 |
Why?
|
| Prevalence | 1 | 2001 | 15211 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1085 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18355 | 0.000 |
Why?
|
| Cell Count | 1 | 1988 | 1855 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1984 | 441 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 570 | 0.000 |
Why?
|
| Algorithms | 1 | 2004 | 13869 | 0.000 |
Why?
|
| Counseling | 1 | 1992 | 1523 | 0.000 |
Why?
|
| Complement Membrane Attack Complex | 1 | 1984 | 112 | 0.000 |
Why?
|
| Poly G | 1 | 1983 | 7 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1984 | 370 | 0.000 |
Why?
|
| Guanosine | 1 | 1983 | 61 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1991 | 1988 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1983 | 353 | 0.000 |
Why?
|
| Complement C2 | 1 | 1982 | 72 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1982 | 81 | 0.000 |
Why?
|
| Phenotype | 2 | 1991 | 16361 | 0.000 |
Why?
|
| Complement C3b | 1 | 1982 | 106 | 0.000 |
Why?
|
| Chemistry | 1 | 1982 | 352 | 0.000 |
Why?
|
| Multigene Family | 1 | 1986 | 1101 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 518 | 0.000 |
Why?
|
| Oocytes | 1 | 1987 | 1186 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1983 | 624 | 0.000 |
Why?
|
| Polynesia | 1 | 1981 | 13 | 0.000 |
Why?
|
| Plasmids | 1 | 1987 | 2308 | 0.000 |
Why?
|
| Space-Time Clustering | 1 | 1981 | 49 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8300 | 0.000 |
Why?
|
| Sheep | 1 | 1984 | 1437 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1987 | 3130 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1983 | 925 | 0.000 |
Why?
|
| Hydroxy Acids | 1 | 1980 | 18 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 153 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 985 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1983 | 1108 | 0.000 |
Why?
|
| Monocytes | 1 | 1988 | 2593 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1982 | 995 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1983 | 662 | 0.000 |
Why?
|
| Lymphatic System | 1 | 1979 | 252 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1982 | 1615 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1982 | 1463 | 0.000 |
Why?
|
| New England | 1 | 1979 | 1022 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1981 | 2419 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1983 | 2203 | 0.000 |
Why?
|
| Pedigree | 1 | 1981 | 4643 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1981 | 6457 | 0.000 |
Why?
|
| Genotype | 1 | 1981 | 12944 | 0.000 |
Why?
|